NOVARTIS AG

NOVN
Delayed Quote. Delayed  - 04/15 11:31:49 am
80.53CHF +0.81%

Turn to zoom
Prev.79.8800
Open80.0000
High80.9200
Low79.7400
Volume3 352 103
Latest news
13h ago
16h ago
18h ago
19h ago
Chart NOVARTIS AG
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishNeutralNeutral
Resistance82,486,186,8
Spread/Res.-2,2%-6,5%-7,3%
Spread/Supp.1,2%13%13%
Support79,671,171,5
Financials
Sales 2021 52 070 M - -
Net income 2021 10 057 M - -
Net Debt 2021 22 868 M - -
P/E ratio 2021 18,8x
Yield 2021 3,77%
Capitalization 197 B 197 B -
EV / Sales 2021 4,22x
EV / Sales 2022 3,95x
Nbr of Employees 105 794
Free-Float 85,6%
Company
Novartis is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- pharmaceutical products (79.5%): used to treat cardiovascular, respiratory, and dermatological diseases, gastrointestinal...

>> Read more
Sector :
Other Pharmaceuticals
Calendar :
2021-04-27 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Mean consensus OUTPERFORM
Number of Analysts 26
Average target price 105,97 $
Last Close Price 87,30 $
Spread / Highest target 70,6%
Spread / Average Target 21,4%
Spread / Lowest Target 3,09%